The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
The neuropathology and cerebrovascular mechanisms of dementia
Open accessAbstract
The prevalence of dementia is increasing in our aging population at an alarming rate. Because of the heterogeneity of clinical presentation and complexity of disease neuropathology, dementia classifications remain controversial. Recently, the National Plan to address Alzheimer’s Disease prioritized Alzheimer’s disease-related dementias to include: Alzheimer’s disease, dementia with Lewy bodies, frontotemporal dementia, vascular dementia, and mixed dementias. While each of these dementing conditions has their unique pathologic signature, one common etiology shared among all these conditions is cerebrovascular dysfunction at some point during the disease process. The goal of this comprehensive review is to summarize the current findings in the field and address the important contributions of cerebrovascular, physiologic, and cellular alterations to cognitive impairment in these human dementias. Specifically, evidence will be presented in support of small-vessel disease as an underlying neuropathologic hallmark of various dementias, while controversial findings will also be highlighted. Finally, the molecular mechanisms shared among all dementia types including hypoxia, oxidative stress, mitochondrial bioenergetics, neuroinflammation, neurodegeneration, and blood–brain barrier permeability responsible for disease etiology and progression will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
RetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“Hypoxia-inducible factor-1 is known to be upregulated during hypoxic stress and to activate a plethora of cellular regulatory factors, including the expression of pro-inflammatory and metabolic genes.(112) Recently our group has found that elevation of hypoxia-inducible factor-1 precedes white matter injury and neuroi…”
BackgroundNeuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“Furthermore, NFT pathology in AD develops in three stages: transentorhinal, limbic, and isocortical, which is the basis of the Braak and Braak staging system of AD,(29) and serves as a better predictor of cognitive decline as compared with A pathology.(30) As a detailed discussion of AD characterization and clinical d…”
ResultThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Pendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Monetary Costs of Dementia in the United States
Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1204629 · Cited by 1,484
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Pathogenesis of Leukoaraiosis: A Review
Pantoni, L., & Garcia, J. H. (1997) · Stroke · doi:10.1161/01.str.28.3.652 · Cited by 1,225
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
Yang, Y., & Rosenberg, G. A. (2011) · Stroke · doi:10.1161/strokeaha.110.608257 · Cited by 789
McKeith, I. G. (2004) · Europe PMC (PubMed Central) · Cited by 756
Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 705
Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · cited 1×
“These pathologic markers positively correlate with neuronal degeneration, neuroinflammation, microglia activation, BBB dysfunction, and cognitive decline.(27,28) Furthermore, NFT pathology in AD develops in three stages: transentorhinal, limbic, and isocortical, which is the basis of the Braak and Braak staging system…”
ResultSelf-citationMcKeith, I., Mintzer, J., Aarsland, D., Burn, D., Chiu, H., Cohen-Mansfield, J., Dickson, D., Dubois, B., Duda, J. E., Feldman, H., et al. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00619-7 · Cited by 618
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603
The neurovascular unit - concept review
Muoio, V., Persson, P. B., & Sendeski, M. M. (2014) · Acta Physiologica · doi:10.1111/apha.12250 · Cited by 564
Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., & Zlokovic, B. V. (2013) · Brain Pathology · doi:10.1111/bpa.12004 · Cited by 553
The epidemiology of frontotemporal dementia
Onyike, C. U., & Diehl-Schmid, J. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.776523 · Cited by 543
Neary, D., Snowden, J., & Mann, D. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70223-4 · Cited by 526
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502
Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
Ryman, D. C., Acosta-Baena, N., Aisen, P. S., Bird, T., Danek, A., Fox, N. C., Goate, A., Frommelt, P., Ghetti, B., Langbaum, J. B. S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000596 · Cited by 502
Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management
Rabinovici, G. D., & Miller, B. L. (2010) · CNS Drugs · doi:10.2165/11533100-000000000-00000 · Cited by 501
Dementia: a global health priority - highlights from an ADI and World Health Organization report
Wortmann, M. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt143 · Cited by 471
Haan, M. N. (1999) · JAMA · doi:10.1001/jama.282.1.40 · Cited by 457
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 445
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
The effects of hypertension on the cerebral circulation
Pires, P. W., Dams Ramos, C. M., Matin, N., & Dorrance, A. M. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00490.2012 · Cited by 408
Mixed Dementia: Emerging Concepts and Therapeutic Implications
Langa, K. M., Foster, N. L., & Larson, E. B. (2004) · JAMA · doi:10.1001/jama.292.23.2901 · Cited by 398
Hawkes, C. A., & McLaurin, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805453106 · Cited by 397
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Vascular cognitive impairment: current concepts and clinical developments
Moorhouse, P., & Rockwood, K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70040-1 · Cited by 358
Jack, C. R., Wiste, H. J., Weigand, S. D., Rocca, W. A., Knopman, D. S., Mielke, M. M., Lowe, V. J., Senjem, M. L., Gunter, J. L., Preboske, G. M., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70194-2 · Cited by 358
Brain Infarction and the Clinical Expression of Alzheimer Disease
Roman, G. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020045023 · Cited by 350
Course of cerebral amyloid angiopathy–related inflammation
Kinnecom, C., Lev, M. H., Wendell, L., Smith, E. E., Rosand, J., Frosch, M. P., & Greenberg, S. M. (2007) · Neurology · doi:10.1212/01.wnl.0000260066.98681.2e · Cited by 333
Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Amariglio, R. E., Rentz, D. M., Johnson, K. A., & Sperling, R. A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2031 · Cited by 328
Wright, A. L., Zinn, R., Hohensinn, B., Konen, L. M., Beynon, S. B., Tan, R. P., Clark, I. A., Abdipranoto, A., & Vissel, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059586 · Cited by 313
Davidson, Y., Kelley, T., Mackenzie, I. R. A., Pickering-Brown, S., Du Plessis, D., Neary, D., Snowden, J. S., & Mann, D. M. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0189-y · Cited by 299
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease
Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Ward, A., Huijbers, W., Rentz, D. M., Johnson, K. A., Sperling, R. A., & For the Alzheimer's Disease Neuroimaging Initiative, T. A. I. B. A. L. F. S. O. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000431 · Cited by 293
Warren, J. D., Rohrer, J. D., & Rossor, M. N. (2013) · BMJ · doi:10.1136/bmj.f4827 · Cited by 292
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
Zotova, E., Nicoll, J. A., Kalaria, R., Holmes, C., & Boche, D. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt24 · Cited by 259
Real-Time In Vivo Imaging Reveals the Ability of Monocytes to Clear Vascular Amyloid Beta
Michaud, J.-P., Bellavance, M.-A., Préfontaine, P., & Rivest, S. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.010 · Cited by 257
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
Blood-brain barrier permeability abnormalities in vascular cognitive impairment
Taheri, S., Gasparovic, C., Huisa, B. N., Adair, J. C., Edmonds, E., Prestopnik, J., Grossetete, M., Shah, N. J., Wills, J., Qualls, C., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.611731 · Cited by 248
Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Skoog, I., Wallin, A., Fredman, P., Hesse, C., Aevarsson, O., Karlsson, I., Gottfries, C. G., & Blennow, K. (1998) · Neurology · doi:10.1212/wnl.50.4.966 · Cited by 241
Carnevale, D., Mascio, G., D'Andrea, I., Fardella, V., Bell, R. D., Branchi, I., Pallante, F., Zlokovic, B., Yan, S. S., & Lembo, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195511 · Cited by 241
Shapira, I. L. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0118 · Cited by 233
Martí-Massó, J. F., & Martínez, J. R. (2000) · PubMed · Cited by 231
AD lesions and infarcts in demented and non‐demented Japanese‐American men
Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., Nelson, J., Hardman, J., Masaki, K., Vogt, M. R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20318 · Cited by 230
Serrano-Pozo, A., Muzikansky, A., Gómez-Isla, T., Growdon, J. H., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182933788 · Cited by 226
Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 223
Vascular Dementia in a Population-Based Autopsy Study
Knopman, D. S., Parisi, J. E., Boeve, B. F., Cha, R. H., Apaydin, H., Salviati, A., Edland, S. D., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.569 · Cited by 221
Iannaccone, S., Cerami, C., Alessio, M., Garibotto, V., Panzacchi, A., Olivieri, S., Gelsomino, G., Moresco, R. M., & Perani, D. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.002 · Cited by 221
Farkas, E., De Jong, G. I., de Vos, R. A. I., Jansen Steur, E. N. H., & Luiten, P. G. M. (2000) · Acta Neuropathologica · doi:10.1007/s004010000195 · Cited by 217
Shah, N. S., Vidal, J.-S., Masaki, K., Petrovitch, H., Ross, G. W., Tilley, C., DeMattos, R. B., Tracy, R. P., White, L. R., & Launer, L. J. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.178962 · Cited by 213
White matter damage is associated with matrix metalloproteinases in vascular dementia
Rosenberg, G. A., Sullivan, N., & Esiri, M. M. (2001) · Stroke · doi:10.1161/01.str.32.5.1162 · Cited by 207
Kaiser, D., Weise, G., Möller, K., Scheibe, J., Pösel, C., Baasch, S., Gawlitza, M., Lobsien, D., Diederich, K., Minnerup, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0169-8 · Cited by 204
Harrison, M. J. G., Thomas, D. J., Du Boulay, G. H., & Marshall, J. (1979) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(79)90195-3 · Cited by 190
Hunter, J. M., Kwan, J., Malek-Ahmadi, M., Maarouf, C. L., Kokjohn, T. A., Belden, C., Sabbagh, M. N., Beach, T. G., & Roher, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036893 · Cited by 178
Ecology of the Aging Human Brain
Sonnen, J. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.157 · Cited by 174 · cited 1×
“Several autopsy studies of nondemented, aged individuals confirm mixed cerebrovascular pathologies and neuropathologic findings, suggesting a complex and silent form of subclinical disease.(18,19) Additional support for this claim is derived from the seminal nun studies.”
ResultSubcortical Ischemic Vascular Dementia
Chui, H. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.003 · Cited by 170
Filiano, A. J., Martens, L. H., Young, A. H., Warmus, B. A., Zhou, P., Diaz-Ramirez, G., Jiao, J., Zhang, Z., Huang, E. J., Gao, F.-B., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.6103-11.2013 · Cited by 170
Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration
Cortes-Canteli, M., Mattei, L., Richards, A. T., Norris, E. H., & Strickland, S. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.030 · Cited by 169
. Identification of Alzheimer and vascular lesion thresholds for mixed dementia.
Gold, G., Giannakopoulos, P., Herrmann, F. R., Bouras, C., & Kovari, E. (2007) · Brain · doi:10.1093/brain/awm228 · Cited by 163
Takeda, S., Sato, N., Takeuchi, D., Kurinami, H., Shinohara, M., Niisato, K., Kano, M., Ogihara, T., Rakugi, H., & Morishita, R. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138586 · Cited by 161
Park, J., Seo, S. W., Kim, C., Kim, G. H., Noh, H. J., Kim, S. T., Kwak, K., Yoon, U., Lee, J. M., Lee, J. W., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23845 · Cited by 159
Endothelial nitric oxide deficiency promotes Alzheimer’s disease pathology
Austin, S. A., Santhanam, A. V., Hinton, D. J., Choi, D., & Katusic, Z. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12334 · Cited by 155
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies
Nedelska, Z., Ferman, T. J., Boeve, B. F., Przybelski, S. A., Lesnick, T. G., Murray, M. E., Gunter, J. L., Senjem, M. L., Vemuri, P., Smith, G. E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.005 · Cited by 155
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
APOE-ε2 and APOE-ε4 Correlate With Increased Amyloid Accumulation in Cerebral Vasculature
Nelson, P. T., Pious, N. M., Jicha, G. A., Wilcock, D. M., Fardo, D. W., Estus, S., & Rebeck, G. W. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829a25b9 · Cited by 150
Scioli, M. G., Bielli, A., Arcuri, G., Ferlosio, A., & Orlandi, A. (2014) · Vascular Cell · doi:10.1186/2045-824x-6-19 · Cited by 150
Myelin Loss Associated With Neuroinflammation in Hypertensive Rats
Jalal, F. Y., Yang, Y. R., Thompson, J., Lopez, A. C., & Rosenberg, G. A. (2012) · Stroke · doi:10.1161/strokeaha.111.643080 · Cited by 148
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease
Davies, A. L., Desai, R. A., Bloomfield, P. S., McIntosh, P. R., Chapple, K. J., Linington, C., Fairless, R., Diem, R., Kasti, M., Murphy, M. P., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24006 · Cited by 147
Yang, Y., Thompson, J. F., Taheri, S., Salayandia, V. M., McAvoy, T. A., Hill, J. W., Yang, Y., Estrada, E. Y., & Rosenberg, G. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.56 · Cited by 147
Schreiber, S., Bueche, C. Z., Garz, C., & Braun, H. (2013) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-5-4 · Cited by 144
Bhaskar, K., Maphis, N. M., Xu, G., Varvel, N. H., Kokiko‐Cochran, O. N., Weick, J. P., Staugaitis, S. M., Cardona, A. E., Ransohoff, R. M., Herrup, K., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.007 · Cited by 143
Self-citationParis, D., Humphrey, J., Quadros, A., Patel, N., Crescentini, R., Crawford, F., & Mullan, M. (2003) · Neurological Research · doi:10.1179/016164103101201940 · Cited by 127
Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP
Jalal, F. Y., Yang, Y. R., Thompson, J. F., Roitbak, T., & Rosenberg, G. A. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.21 · Cited by 125
Connecting the dots between tau dysfunction and neurodegeneration
Frost, B., Götz, J., & Feany, M. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.005 · Cited by 124
Activated microglia in dementia with Lewy bodies
Mackenzie, I. R. (2000) · Neurology · doi:10.1212/wnl.55.1.132 · Cited by 124
Recommendations of the Alzheimer's Disease–Related Dementias Conference
Montine, T. J., Koroshetz, W. J., Babcock, D., Dickson, D. W., Galpern, W. R., Glymour, M. M., Greenberg, S. M., Hutton, M. L., Knopman, D. S., Kuzmichev, A. N., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000733 · Cited by 122
Butterfield, D. A., Domenico, F. D., Swomley, A. M., Head, E., & Marzia Perluigi, A. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 112
Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease
Cifuentes, D., Poittevin, M., Dere, E., Broquères-You, D., Bonnin, P., Benessiano, J., Pocard, M., Mariani, J., Kubis, N., Merkulova-Rainon, T., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04139 · Cited by 111
Ferrer, I., Gómez, A., Carmona, M., Huesa, G., Porta, S., Riera‐Codina, M., Biagioli, M., Gustincich, S., & Aso, E. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101485 · Cited by 110
Kalkonde, Y. V., Jawaid, A., Qureshi, S. U., Shirani, P., Wheaton, M. W., Pinto-Patarroyo, G. P., & Schulz, P. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.03.011 · Cited by 109
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions
Villeneuve, S., Reed, B., Madison, C. M., Wirth, M., Marchant, N. L., Kriger, S., Mack, W. J., Sanossian, N., DeCarli, C. S., Chui, H. C., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000550 · Cited by 103
Rosenberg, G. A., Bjerke, M., & Wallin, A. (2014) · Stroke · doi:10.1161/strokeaha.113.004534 · Cited by 103
Blood brain barrier function in vascular dementia
Wallin, A., Blennow, K., Fredman, P., Gottfries, C. G., Karlsson, I., & Svennerholm, L. T. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb01562.x · Cited by 102
Bellucci, A., Bugiani, O., Ghetti, B. F., & Spillantini, M. G. (2011) · Neurodegenerative Diseases · doi:10.1159/000322228 · Cited by 99
Barber, R., Gholkar, A. R., Scheltens, P., Ballard, C. G., McKeith, I. G., & O'Brien, J. T. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200010)15:10<911::aid-gps217>3.0.co;2-t · Cited by 96
Chuang, J., Lee, C.-W., Shih, Y., Yang, T., Yu, L., & Kuo, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033120 · Cited by 95
Recent Updates on Subcortical Ischemic Vascular Dementia
Roh, J. H., & Lee, J.-H. (2014) · Journal of Stroke · doi:10.5853/jos.2014.16.1.18 · Cited by 93
Ghebremedhin, E., Rosenberger, A., Rüb, U., Vukšić, M., Berhe, T., Bickeböller, H., de Vos, R. A. I., Thal, D. R., & Deller, T. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d88e63 · Cited by 89
Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors
Miwa, K., Tanaka, M., Okazaki, S., Yagita, Y., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2014) · Neurology · doi:10.1212/wnl.0000000000000692 · Cited by 86
A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain
Fujita, M., Sugama, S., Sekiyama, K., Sekigawa, A., Tsukui, T., Nakai, M., Waragai, M., Takenouchi, T., Takamatsu, Y., Wei, J., et al. (2010) · Nature Communications · doi:10.1038/ncomms1101 · Cited by 84
Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells
Dietrich, H. H., Xiang, C., Han, B. H., Zipfel, G. J., & Holtzman, D. M. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-15 · Cited by 81
Stefani, A., Sancesario, G., Pierantozzi, M., Leone, G., Galati, S., Hainsworth, A. H., & Diomedi, M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.343 · Cited by 80 · cited 1×
“Moreover, hemodynamic impairment of mean blood flow velocity, pulsatility index, and cerebrovascular reactivity were found in AD patients as compared with controls using transcranial Doppler to monitor the middle cerebral artery.(13) These results suggest hemodynamic impairment as a critical marker of cognitive declin…”
ResultSantaCruz, K. S., Sonnen, J. A., Pezhouh, M. K., Desrosiers, M. F., Nelson, P. T., & Tyas, S. L. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822e8ae9 · Cited by 79
Perri, R., Monaco, M., Fadda, L., Caltagirone, C., & Carlesimo, G. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131337 · Cited by 72
Maetzler, W., Berg, D., Synofzik, M., Brockmann, K., Godau, J., Melms, A., Gasser, T., Hörnig, S., & Langkamp, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110221 · Cited by 71
Cardiovascular risk factors and frontotemporal dementia: a case–control study
Golimstok, Á., Cámpora, N., Rojas, J. I., Fernández, M. C., Elizondo, C. M., Soriano, E. R., & Cristiano, E. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-13 · Cited by 71
Thal, D. R., von Arnim, C. A. F., Griffin, W. S. T., Mrak, R. E., Walker, L., Attems, J., & Arzberger, T. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1360-6 · Cited by 67
Hattori, Y., Okamoto, Y., Maki, T., Yamamoto, Y., Oishi, N., Yamahara, K., Nagatsuka, K., Takahashi, R., Kalaria, R. N., Fukuyama, H., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006265 · Cited by 64
Reuck, J. D., Deramecourt, V., Auger, F., Durieux, N., Cordonnier, C., Devos, D., Defebvre, L., Moreau, C., Caparros-Lefebvre, D., Bordet, R., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.07.061 · Cited by 63
Foster, V., Oakley, A. E., Slade, J. Y., Hall, R., Polvikoski, T. M., Burke, M., Thomas, A. J., Khundakar, A., Allan, L. M., & Kalaria, R. N. (2014) · Brain · doi:10.1093/brain/awu172 · Cited by 62 · cited 1×
“Third, clinicopathologic reports of VaD patients demonstrate regional pyramidal neuronal atrophy in the dorsolateral prefrontal cortex, corresponding with diminished executive function, suggesting a vascular basis for the highly specific pyramidal neuron atrophy in individuals with dementia.(132) Finally, previous stu…”
BackgroundClinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review
Pan, X., & Chen, X. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-8 · Cited by 58
Critical analysis of Alzheimer rsquo s amyloid-beta nbsp toxicity to mitochondria
Kaminsky, Y. G., Tikhonova, L. A., & Kosenko, E. A. (2015) · Frontiers in bioscience · doi:10.2741/4304 · Cited by 57
Schreiber, S., Drukarch, B., Garz, C., Niklass, S., Stanaszek, L., Kropf, S., Bueche, C. Z., Held, F., Vielhaber, S., Attems, J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132618 · Cited by 55
de Villota, E. D., Carmona, M. T. G., RUBIO, J. J., et al. (1981) · British Journal of Anaesthesia · doi:10.1093/bja/53.12.1325 · Cited by 54
Valenti, R., Pantoni, L., & Markus, H. S. (2014) · BMC Medicine · doi:10.1186/s12916-014-0160-z · Cited by 51
Clinicopathologic study of Alzheimer’s disease: Alzheimer mimics
Shim, Y. S., Roe, C. M., Buckles, V. D., & Morris, J. C. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121594 · Cited by 49
Neuropathology and general autopsy findings in nondemented aged subjects
Jellinger, K. A., & Attems, J. (2012) · Clinical Neuropathology · doi:10.5414/np300418 · Cited by 48 · cited 1×
“Several autopsy studies of nondemented, aged individuals confirm mixed cerebrovascular pathologies and neuropathologic findings, suggesting a complex and silent form of subclinical disease.(18,19) Additional support for this claim is derived from the seminal nun studies.”
ResultNägga, K., Wattmo, C., Zhang, Y., Wahlund, L., & Palmqvist, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt271 · Cited by 47
Age-Related Defects in Erythrocyte 2,3-Diphosphoglycerate Metabolism in Dementia
Kaminsky, Y. G. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400244 · Cited by 46
Miners, J. S., Moulding, H., de Silva, R., & Love, S. (2014) · Brain Pathology · doi:10.1111/bpa.12130 · Cited by 45
Reuck, J. D., Deramecourt, V., Cordonnier, C., Auger, F., Durieux, N., Bordet, R., Maurage, C., Leys, D., & Pasquier, F. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03776.x · Cited by 45
Using Structural and Diffusion Magnetic Resonance Imaging To Differentiate the Dementias
Suri, S., Topiwala, A., Mackay, C. E., Ebmeier, K. P., & Filippini, N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0475-3 · Cited by 42
Prevalence of cerebrovascular lesions in patients with Lewy body dementia: A neuropathological study
Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Pasquier, F., & Maurage, C. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.11.005 · Cited by 41
Optical imaging in an Alzheimer’s mouse model reveals amyloid-β-dependent vascular impairment
Lin, A. J., Liu, G., Castello, N. A., Yeh, J. J., Rahimian, R., Lee, G., Tsay, V., Durkin, A. J., Choi, B., LaFerla, F. M., et al. (2014) · Neurophotonics · doi:10.1117/1.nph.1.1.011005 · Cited by 41
Weaver, J. M. R., Jalal, F. Y., Yang, Y. R., Thompson, J., Rosenberg, G. A., & Liu, K. J. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.35 · Cited by 40
Hypertension drives parenchymal β‐amyloid accumulation in the brain parenchyma
Bueche, C. Z., Hawkes, C. A., Garz, C., Vielhaber, S., Attems, J., Knight, R. T., Reymann, K. G., Heinze, H., Carare, R. O., & Schreiber, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.27 · Cited by 36
Traumatic Brain Injury May Increase the Risk for Frontotemporal Dementia through Reduced Progranulin
Jawaid, A., Rademakers, R., Kass, J. S., Kalkonde, Y. V., & Schulz, P. E. (2009) · Neurodegenerative Diseases · doi:10.1159/000258704 · Cited by 36
Mid-life Cardiovascular Risk Impacts Memory Function: The Framingham Offspring Study
Gupta, A., Preis, S. R., Beiser, A., Devine, S., Hankee, L. D., Seshadri, S. S., Wolf, P. A., & Au, R. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000059 · Cited by 32
The Role of -Amyloid in Alzheimer's Disease-Related Neurodegeneration
Goldsworthy, M. R., & Vallence, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2252-13.2013 · Cited by 29
Nielsen, H. M., Palmqvist, S., Minthon, L., Londos, E., & Wennström, M. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107537 · Cited by 29
Ritz, M., Grond‐Ginsbach, C., Engelter, S. T., & Lyrer, P. A. (2012) · Current Neurovascular Research · doi:10.2174/156720212799297074 · Cited by 26
TDP-43 and frontotemporal dementia
Hu, W. T., & Grossman, M. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0052-3 · Cited by 24
A cortical form of CADASIL with cerebral Aβ amyloidosis
Paquet, C., Jouvent, É., Miné, M., Vital, A., Hugon, J., Chabriat, H., & Gray, F. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0758-y · Cited by 19
Mariani, C., Defendi, S., Mailland, E., et al. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0544-8 · Cited by 19
Thomason, L. A. M., Stefanovic, B., & McLaurin, J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12181 · Cited by 9
Cited by
Obesity-Induced Neuroinflammation: Beyond the Hypothalamus
Guillemot-Legris, O., & Muccioli, G. G. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.02.005 · Cited by 563
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 382
Janelidze, S., Hertze, J., Nägga, K., Nilsson, K., Nilsson, C., Wennström, M., van Westen, D., Blennow, K., Zetterberg, H., & Hansson, O. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.017 · Cited by 237
Chronic inflammation in multiple sclerosis - seeing what was always there
Matthews, P. M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0240-y · Cited by 128
Salinas, J., Beiser, A. S., Samra, J. K., O'Donnell, A., DeCarli, C. S., Gonzales, M. M., Aparicio, H. J., & Seshadri, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200039 · Cited by 127
Metadata
- Authors
- Raz, L., Knoefel, J., & Bhaskar, K.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2015-07-15
- Volume
- 36
- Issue
- 1
- Pages
- 172-186
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W1855997172
- Cited by
- 470
- References
- 153
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.